CM
BBIO icon

Caption Management’s BridgeBio Pharma BBIO Stock Holding History

Caption Management’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.45M Buy
100,000
+40,000
+67% +$2.8M 0.03% 471
2026
Q1 		$4.46M Sell
60,000
-140,000
-70% -$10.1M 0.03% 563
2025
Q4 		$15.3M Buy
200,000
+50,000
+33% +$3.28M 0.1% 232
2025
Q3 		$7.79M Buy
150,000
+80,000
+114% +$3.9M 0.06% 352
2025
Q2 		$3.02M Sell
70,000
-226,500
-76% -$8.24M 0.03% 582
2025
Q1 		$10.3M Buy
296,500
+186,500
+170% +$6.29M 0.1% 201
2024
Q4 		$3.02M Sell
110,000
-180,100
-62% -$4.65M 0.03% 550
2024
Q3 		$7.39M Sell
290,100
-598,400
-67% -$15.7M 0.12% 206
2024
Q2 		$22.5M Buy
888,500
+383,200
+76% +$10.5M 0.35% 60
2024
Q1 		$15.6M Buy
505,300
+475,300
+1,584% +$16.2M 0.24% 105
2023
Q4 		$1.21M Buy
30,000
+200
+0.7% +$6.01K 0.02% 761
2023
Q3 		$786K Sell
29,800
-705,900
-96% -$20M 0.01% 834
2023
Q2 		$12.7M Buy
735,700
+590,700
+407% +$8.89M 0.22% 111
2023
Q1 		$2.4M Buy
+145,000
New +$1.69M 0.05% 401
2022
Q4 		– Sell
-57,500
Closed -$573K – 1288
2022
Q3 		$573K Sell
57,500
-5,000
-8% -$51.9K 0.01% 1038
2022
Q2 		$568K Buy
62,500
+12,500
+25% +$105K 0.01% 1045
2022
Q1 		$507K Sell
50,000
-795,800
-94% -$8.17M 0.01% 1140
2021
Q4 		$14.1M Buy
+845,800
New +$35.8M 0.16% 164
2020
Q4 		– Sell
-12,500
Closed -$469K – 969
2020
Q3 		$469K Buy
+12,500
New +$393K 0.01% 783

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Caption Management's BBIO Position: Q2 2026 in Review

Caption Management sold out of BridgeBio Pharma (BBIO) in Q2 2026, closing a stake of 431 shares — an estimated $30.2K sold.

Caption Management first reported a position in BBIO in Q4 2021 and held it in 9 quarters. The position peaked at $10.3M in Q2 2024. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Caption Management reported no remaining BridgeBio Pharma position as of Q2 2026 after selling out during the quarter.
  • Caption Management sold 431 BridgeBio Pharma shares in Q2 2026, an estimated $30.2K.
  • Caption Management first reported a position in BridgeBio Pharma in Q4 2021 and held it in 9 quarters.
  • Caption Management's BridgeBio Pharma position peaked at $10.3M in Q2 2024.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.